» Authors » Masayuki Yamamoto

Masayuki Yamamoto

Explore the profile of Masayuki Yamamoto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 1015
Citations 57150
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cuadrado A, Cazalla E, Bach A, Bathish B, Naidu S, DeNicola G, et al.
Redox Biol . 2025 Mar; :103569. PMID: 40059038
Nuclear factor erythroid 2-related factor 2 (NRF2) is a redox-activated transcription factor regulating cellular defense against oxidative stress, thereby playing a pivotal role in maintaining cellular homeostasis. Its dysregulation is...
2.
Ishida S, Taguchi K, Iida R, Hattori K, Taketsuru H, Yoshimi K, et al.
Exp Anim . 2025 Jan; PMID: 39842783
Rats (Rattus norvegicus) have been widely utilized as model animals due to their physiological characteristics, making them suitable for surgical and long-term studies. They have played a crucial role in...
3.
Ohneda K, Suzuki Y, Hamanaka Y, Tadaka S, Shimada M, Hasegawa-Minato J, et al.
J Hum Genet . 2025 Jan; 70(3):147-157. PMID: 39825003
Large-scale population cohort studies that collect genomic information are tasked with returning an assessment of genetic risk for hereditary cancers to participants. While several studies have applied to return identified...
4.
Mori N, Mugikura S, Hozawa A, Taira M, Hashizume H, Sekiguchi A, et al.
Tohoku J Exp Med . 2025 Jan; PMID: 39814398
No abstract available.
5.
Aoyama Y, Yamazaki H, Nishimura K, Nishimua K, Nomura M, Shigehiro T, et al.
Blood . 2025 Jan; 145(11):1149-1163. PMID: 39775457
The maintenance of cellular redox balance is crucial for cell survival and homeostasis and is disrupted with aging. Selenoproteins, comprising essential antioxidant enzymes, raise intriguing questions about their involvement in...
6.
Chu C, Uruno A, Katsuoka F, Yamamoto M
Antioxidants (Basel) . 2025 Jan; 13(12. PMID: 39765857
Alzheimer's disease (AD) is a polygenic, multifactorial neurodegenerative disorder and remains the most prevalent form of dementia, globally. Despite decades of research efforts, there is still no effective cure for...
7.
Oshikiri H, Taguchi K, Hirose W, Taniyama Y, Kamei T, Siegel D, et al.
Mol Cell Biol . 2024 Dec; 45(2):79-97. PMID: 39717011
In esophageal squamous cell carcinoma, genetic activation of NRF2 increases resistance to chemotherapy and radiotherapy, which results in a significantly worse prognosis for patients. Therefore NRF2-activated cancers create an urgent...
8.
Murakami K, Nakadate M, Obara T, Aizawa M, Takahashi I, Ishikuro M, et al.
J Epidemiol . 2024 Dec; PMID: 39710420
Background: The Tohoku Medical Megabank Project has initiated the Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study) including genomic and omics investigations, and conducted a self-administered food frequency questionnaire...
9.
Iwamura Y, Nakai T, Kato K, Ishioka H, Yamamoto M, Hirano I, et al.
Mol Cell Biol . 2024 Dec; 45(1):32-45. PMID: 39620278
During mammalian development, production sites of the erythroid growth factor erythropoietin (EPO) shift from the neural tissues to the liver in embryos and to the kidneys in adults. Embryonic neural...
10.
Sekine H, Takeda H, Takeda N, Kishino A, Anzawa H, Isagawa T, et al.
Nat Metab . 2024 Nov; 6(12):2391. PMID: 39592844
No abstract available.